Literature DB >> 8240252

Econazole inhibits thapsigargin-induced platelet calcium influx by mechanisms other than cytochrome P-450 inhibition.

J G Vostal1, J C Fratantoni.   

Abstract

Cytochrome P-450 has been suggested as a mediator of the signal between depleted platelet calcium stores and an increase in plasma membrane permeability to calcium which follows depletion of the stores. This hypothesis is based on the observations that inhibitors of cytochrome P-450, such as the imidazole antifungal agents, also inhibit influx of a calcium surrogate (manganese) into calcium-depleted platelets. We tested the effects of econazole and of a cytochrome P-450 inhibitor, carbon monoxide (CO), on thapsigargin (TG)-induced platelet 45Ca2+ influx. TG specifically depletes internal calcium stores and activates store-regulated calcium influx. Econazole blocked 45Ca2+ influx when it was added before TG (IC50 11 microM). Econazole at a concentration (20 microM) that inhibited 83% of TG-induced calcium influx was not inhibitory to TG-induced calcium efflux from 45Ca(2+)-loaded platelets, and did not affect calcium fluxes in resting platelets. This econazole concentration was also inhibitory to calcium influx even when it was added after the stores had been calcium-depleted by EGTA and TG for 15 min and the signal to increase calcium influx had already been generated. Inhibition of cytochrome P-450 with CO bubbled through platelet suspensions did not change calcium influx in resting cells and potentiated TG-induced calcium influx (160% of control calcium accumulation at 20 min). This effect appeared to be concentration-dependent, such that a 5 min exposure to CO produced a greater influx potentiation than a 3 min exposure. These observations indicate that (1) cytochrome P-450 does not mediate store-regulated calcium influx, and (2) econazole probably inhibits store-regulated calcium influx by an alternative mechanism, such as interaction with plasma membrane calcium channels.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240252      PMCID: PMC1134911          DOI: 10.1042/bj2950525

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  31 in total

1.  Platelet cytochrome P450: a possible role in arachidonate-induced aggregation.

Authors:  D L Cinti; M B Feinstein
Journal:  Biochem Biophys Res Commun       Date:  1976-11-08       Impact factor: 3.575

2.  Ca2+ homeostasis in unstimulated platelets.

Authors:  L F Brass
Journal:  J Biol Chem       Date:  1984-10-25       Impact factor: 5.157

3.  Inhibition of platelet ADP and serotonin release by carbon monoxide and in cigarette smokers.

Authors:  A Mansouri; C A Perry
Journal:  Experientia       Date:  1984-05-15

4.  Alteration of platelet aggregation by cigarette smoke and carbon monoxide.

Authors:  A Mansouri; C A Perry
Journal:  Thromb Haemost       Date:  1982-12-27       Impact factor: 5.249

5.  Control of Ca2+ entry into HL60 and U937 human leukaemia cells by the filling state of the intracellular Ca2+ stores.

Authors:  S R Alonso-Torre; J Alvarez; M Montero; A Sanchez; J García-Sancho
Journal:  Biochem J       Date:  1993-02-01       Impact factor: 3.857

6.  Modulation of purified phospholipase A2 activity from human platelets by calcium and indomethacin.

Authors:  R L Jesse; R C Franson
Journal:  Biochim Biophys Acta       Date:  1979-12-18

7.  The calcium mobilizing tumor promoting agent, thapsigargin elevates the platelet cytoplasmic free calcium concentration to a higher steady state level. A possible mechanism of action for the tumor promotion.

Authors:  O Thastrup; B Foder; O Scharff
Journal:  Biochem Biophys Res Commun       Date:  1987-02-13       Impact factor: 3.575

8.  Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme.

Authors:  M Haurand; V Ullrich
Journal:  J Biol Chem       Date:  1985-12-05       Impact factor: 5.157

9.  Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase.

Authors:  B Brüne; V Ullrich
Journal:  Mol Pharmacol       Date:  1987-10       Impact factor: 4.436

10.  Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism.

Authors:  J Capdevila; L Gil; M Orellana; L J Marnett; J I Mason; P Yadagiri; J R Falck
Journal:  Arch Biochem Biophys       Date:  1988-03       Impact factor: 4.013

View more
  6 in total

1.  Extracellular site for econazole-mediated block of Ca2+ release-activated Ca2+ current (Icrac) in T lymphocytes.

Authors:  E P Christian; K T Spence; J A Togo; P G Dargis; E Warawa
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation.

Authors:  H C Köfeler; G Fauler; W Windischhofer; H J Leis
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Mechanisms of the thapsigargin-induced Ca(2+) entry in in situ endothelial cells of the porcine aortic valve and the endothelium-dependent relaxation in the porcine coronary artery.

Authors:  M Kuroiwa-Matsumoto; K Hirano; A Ahmed; J Kawasaki; J Nishimura; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

4.  Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane.

Authors:  A J Morgan; R Jacob
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

5.  Pharmacology of a Ca(2+)-influx pathway activated by emptying the intracellular Ca2+ stores in HL-60 cells: evidence that a cytochrome P-450 is not involved.

Authors:  B D Koch; G F Faurot; M V Kopanitsa; D C Swinney
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

Review 6.  The effect of emerging tobacco related products and their toxic constituents on thrombosis.

Authors:  Ahmed B Alarabi; Patricia A Lozano; Fadi T Khasawneh; Fatima Z Alshbool
Journal:  Life Sci       Date:  2021-12-23       Impact factor: 6.780

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.